Endocrinology & Metabolic Syndrome
Open Access

Mehmet Eren

Publications

• Research Article
  Presence of Metabolic Syndrome is not an Independent Predictor of In-hospital Adverse Events in Patients with ST Elevation Myocardial Infarction that Underwent Primary Percutaneous Coronary Intervention
  Author(s): Ahmet Ekmekci, Baris Gungor, Mahmut Uluganyan, Kazim Serhan Ozcan, Mehmet Bozbay, Gokhan Cicek, Aycan Zencirci, Gokhan Ertas, Dilaver Oz, Hatice Betul Erer, Nurten Sayar and Mehmet Eren Ahmet Ekmekci, Baris Gungor, Mahmut Uluganyan, Kazim Serhan Ozcan, Mehmet Bozbay, Gokhan Cicek, Aycan Zencirci, Gokhan Ertas, Dilaver Oz, Hatice Betul Erer, Nurten Sayar and Mehmet Eren
  
  Background: Presence of Metabolic Syndrome (MetS) has been shown to predict higher risk for cardiovascular diseases. However, in patients with ST Segment Elevation Myocardial Infarction (STEMI), prognostic importance of MetS has not been widely studied. Methods: We prospectively recruited 611 STEMI patients (521 male, 90 female) who were treated by primary angioplasty. Metabolic syndrome was diagnosed according to the International Diabetes Federation metabolic syndrome worldwide definition. Coronary angiographic data and in-hospital events of individuals were recorded. Major Adverse Cardiac Events (MACE) included cardiac death, recurrent myocardial infarction and target lesion revascularization. Results: Metabolic syndrome group included 276 (45.1% of the study cohort; mean age 56.8 ± 12.2; 210 male) and control group included 335 su.. View More»
  DOI: 10.4172/2161-1017.1000112

  Abstract PDF

Relevant Topics